The forecast for systemic hormonal preparations sales in Germany, excluding sex hormones and insulins, demonstrates a consistent upward trend from 2024 to 2028, with values increasing from 19.2 USD per capita in 2024 to 20.8 USD per capita in 2028. Given the steady increments, the average year-on-year growth rate is approximately 1.5%.
In 2023, systemic hormonal preparations stood around 18.8 USD per capita, illustrating a positive trajectory in this market segment, which is indicative of increasing demand. The compound annual growth rate (CAGR) over this five-year span is around 1.8%.
Future trends to watch for include:
- Technological and innovative advancements in hormonal therapies.
- Changes in healthcare policies impacting drug pricing and accessibility.
- Demographic shifts and their influence on market demand.
